Krishnan Suma 的 Form 4 申報
Krystal Biotech, Inc.（KRYS），2023/4/18 申報
- 申報編號
- 0001298711-23-000012
- 申報時間
- 2023/4/18
- 交易日
- 2023/4/17
- 申報延遲
- 1 天
- 10b5-1 計畫
- 有勾選
這份申報列了 10 筆非衍生性交易。公開市場賣出合計 $438.3 萬。交易後 1 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Krishnan SumaCIK 0001298711 | 董事、高階主管（President, R&D）、持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/4/17 | Common Stock | S賣出處分 | −1,050 | $85.55F2 | −$89,827.5 | 1,673,156 | 直接 | |
| 2023/4/17 | Common Stock | S賣出處分 | −4,297 | $86.80F3 | −$372,979.6 | 1,668,859 | 直接 | |
| 2023/4/17 | Common Stock | S賣出處分 | −9,429 | $87.41F4 | −$824,188.89 | 1,659,430 | 直接 | |
| 2023/4/17 | Common Stock | S賣出處分 | −9,724 | $88.41F5 | −$859,698.84 | 1,649,706 | 直接 | |
| 2023/4/17 | Common Stock | S賣出處分 | −500 | $89.12F6 | −$44,560 | 1,649,206 | 直接 | |
| 2023/4/17 | Common Stock | S賣出處分 | −1,050 | $85.55F2 | −$89,827.5 | 1,737,638 | 間接 | |
| 2023/4/17 | Common Stock | S賣出處分 | −4,298 | $86.80F3 | −$373,066.4 | 1,733,340 | 間接 | |
| 2023/4/17 | Common Stock | S賣出處分 | −9,428 | $87.41F4 | −$824,101.48 | 1,723,912 | 間接 | |
| 2023/4/17 | Common Stock | S賣出處分 | −9,724 | $88.41F5 | −$859,698.84 | 1,714,188 | 間接 | |
| 2023/4/17 | Common Stock | S賣出處分 | −500 | $89.12F6 | −$44,560 | 1,713,688 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The transaction was executed in multiple trades ranging from $85.0500 to $86.0000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 2 筆交易的價格引用這則附註。
- F3
The transaction was executed in multiple trades ranging from $86.0500 to $87.0450. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 2 筆交易的價格引用這則附註。
- F4
The transaction was executed in multiple trades ranging from $87.0500 to $88.0300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 2 筆交易的價格引用這則附註。
- F5
The transaction was executed in multiple trades ranging from $88.0500 to $89.0100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 2 筆交易的價格引用這則附註。
- F6
The transaction was executed in multiple trades ranging from $89.0650 to $89.2300. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 2 筆交易的價格引用這則附註。